These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 29222770)

  • 1. Ocular Nerve Growth Factor (NGF) and NGF Eye Drop Application as Paradigms to Investigate NGF Neuroprotective and Reparative Actions.
    Tirassa P; Rosso P; Iannitelli A
    Methods Mol Biol; 2018; 1727():19-38. PubMed ID: 29222770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Time-dependent activation of c-fos in limbic brain areas by ocular administration of nerve growth factor in adult rats.
    Calza A; Florenzano F; Pellegrini D; Tirassa P
    J Ocul Pharmacol Ther; 2011 Jun; 27(3):209-18. PubMed ID: 21510807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nerve growth factor eye drop administrated on the ocular surface of rodents affects the nucleus basalis and septum: biochemical and structural evidence.
    Lambiase A; Pagani L; Di Fausto V; Sposato V; Coassin M; Bonini S; Aloe L
    Brain Res; 2007 Jan; 1127(1):45-51. PubMed ID: 17113055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroprotective role of nerve growth factor in hypoxicischemic injury. From brain to skin.
    Chiaretti A; Falsini B; Aloe L; Pierri F; Fantacci C; Riccardi R
    Arch Ital Biol; 2011 Jun; 149(2):275-82. PubMed ID: 21702000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nerve growth factor eye drops to treat glaucoma.
    Lambiase A; Mantelli F; Bonini S
    Drug News Perspect; 2010; 23(6):361-7. PubMed ID: 20697603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Painless Nerve Growth Factor: A TrkA biased agonist mediating a broad neuroprotection via its actions on microglia cells.
    Cattaneo A; Capsoni S
    Pharmacol Res; 2019 Jan; 139():17-25. PubMed ID: 30391352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nerve growth factor eye drop administration improves visual function in a patient with optic glioma.
    Chiaretti A; Falsini B; Servidei S; Marangoni D; Pierri F; Riccardi R
    Neurorehabil Neural Repair; 2011 May; 25(4):386-90. PubMed ID: 21343523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intranasal "painless" human Nerve Growth Factor [corrected] slows amyloid neurodegeneration and prevents memory deficits in App X PS1 mice.
    Capsoni S; Marinelli S; Ceci M; Vignone D; Amato G; Malerba F; Paoletti F; Meli G; Viegi A; Pavone F; Cattaneo A
    PLoS One; 2012; 7(5):e37555. PubMed ID: 22666365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Nerve growth factor in neurodegeneration and neurorestorative therapy].
    Lorigados-Pedre L; Bergado-Rosado J
    Rev Neurol; 2004 May 16-31; 38(10):957-71. PubMed ID: 15175980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eye drop delivery of pigment epithelium-derived factor-34 promotes retinal ganglion cell neuroprotection and axon regeneration.
    Vigneswara V; Esmaeili M; Deer L; Berry M; Logan A; Ahmed Z
    Mol Cell Neurosci; 2015 Sep; 68():212-21. PubMed ID: 26260110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The nerve growth factor administrated as eye drops activates mature and precursor cells in subventricular zone of adult rats.
    Tirassa P
    Arch Ital Biol; 2011 Jun; 149(2):205-13. PubMed ID: 21701992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular and neuronal protection induced by the ocular administration of nerve growth factor in diabetic-induced rat encephalopathy.
    Tirassa P; Maccarone M; Florenzano F; Cartolano S; De Nicolò S
    CNS Neurosci Ther; 2013 May; 19(5):307-18. PubMed ID: 23528019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of Bradykinin Receptor 2 in Nerve Growth Factor Neuroprotective Activity.
    Petrella C; Ciotti MT; Nisticò R; Piccinin S; Calissano P; Capsoni S; Mercanti D; Cavallaro S; Possenti R; Severini C
    Cells; 2020 Dec; 9(12):. PubMed ID: 33321704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ocular nerve growth factor administration counteracts the impairment of neural precursor cell viability and differentiation in the brain subventricular area of rats with streptozotocin-induced diabetes.
    Tirassa P; Maccarone M; Carito V; De Nicolò S; Fiore M
    Eur J Neurosci; 2015 May; 41(9):1207-18. PubMed ID: 25728260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of conjunctivally applied nerve growth factor in the retina and optic nerve of adult rats.
    Lambiase A; Tirassa P; Micera A; Aloe L; Bonini S
    Invest Ophthalmol Vis Sci; 2005 Oct; 46(10):3800-6. PubMed ID: 16186366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eye drop NGF administration promotes the recovery of chemically injured cholinergic neurons of adult mouse forebrain.
    Di Fausto V; Fiore M; Tirassa P; Lambiase A; Aloe L
    Eur J Neurosci; 2007 Nov; 26(9):2473-80. PubMed ID: 17970722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical applications of NGF in ocular diseases.
    Lambiase A; Mantelli F; Sacchetti M; Rossi S; Aloe L; Bonini S
    Arch Ital Biol; 2011 Jun; 149(2):283-92. PubMed ID: 21702001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of nerve growth factor for retinal cell survival in experimental retinal detachment.
    Sun X; Xu X; Wang F; Zhang X; Yu Z; Lu H; Ho PC
    Curr Eye Res; 2007 Sep; 32(9):765-72. PubMed ID: 17882709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Neutrophins in biology and medicine].
    Woszczycka-Korczyńska I; Lewin-Kowalik J; Górka D; Olakowska E
    Pol Merkur Lekarski; 2006 May; 20(119):602-5. PubMed ID: 16875172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurotrophins in the developing and regenerating visual system.
    von Bartheld CS
    Histol Histopathol; 1998 Apr; 13(2):437-59. PubMed ID: 9589902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.